AMENDMENT NO. 3 TO Capital on Demand™ SALES AGREEMENTCapital on Demand™ Sales Agreement • March 11th, 2019 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • New York
ARCA biopharma, Inc., a Delaware corporation (the “Company”), and JonesTrading Institutional Services LLC (the “Agent”), are parties to that certain Capital on Demand™ Sales Agreement dated January 11, 2017, as amended on August 21, 2017 and January 25, 2019 (together, the “Original Agreement”). All capitalized terms not defined herein shall have the meanings ascribed to them in the Original Agreement. The parties, intending to be legally bound, hereby amend the Original Agreement pursuant to the terms of this amendment No. 3 to the Original Agreement (this “Amendment No. 3”) as follows:
